IBSRELA
Identification of Ibsrela
| No description |
Google image searchProduct monograph
Active ingredient
tenapanor (tenapanor hydrochloride), 50 MG
DIN: 02498049
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: KNIGHT THERAPEUTICS INC.
Date: 23-NOV-2020
ATC:
- A06 — LAXATIVES (ATC, ATC/DDD, )
- A06A — LAXATIVES (ATC, ATC/DDD)
- A06AX — Other laxatives (ATC, ATC/DDD)
- A06AX08 — TENAPANOR (ATC/DDD)
Reference brand drug: Ibsrela
